Irving Scholar Elizabeth Hillman, PhD, and her team received a $24 million UM1 center grant and a $150 million BRAIN CONNECTS initiative for new ambitious project.
Dr. Jennifer Manly, one of Irving Institute's 2022 Senior Mentors of the Year, weighs in on the efficacy of new Alzheimer's drug, donanemab, that may be approved in the US this year.
Interview with Hiral Shah, MD, assistant professor of neurology, about her work addressing the health disparities for Parkinson's disease diagnosis and treatment faced by minority communities.
The overarching goal of Dr. Spann’s research is to identify early immune, brain, and neuropsychological antecedents of childhood psychiatric risk to reduce the time to intervention for young children